These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3458691

  • 1. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
    Okura A, Arakawa H, Yoshinari T, Naito K, Ishizuka M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Apr; 39(4):575-80. PubMed ID: 3458691
    [Abstract] [Full Text] [Related]

  • 2. Effect of forphenicinol on gamma-interferon production in mice sensitized with BCG.
    Okura A, Nakadaira M, Naito K, Ishizuka M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Apr; 39(4):569-74. PubMed ID: 3011721
    [Abstract] [Full Text] [Related]

  • 3. Studies on effects of forphenicinol on immune responses.
    Ishizuka M, Ishizeki S, Masuda T, Momose A, Aoyagi T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1982 Aug; 35(8):1042-8. PubMed ID: 7142005
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. I-Ad antigen expression of pyran copolymer-induced peritoneal cells in tumor vaccine-primed mice and its association with the host antitumor response.
    Oh-hashi F, Kataoka T, Taniyama T.
    Cancer Immunol Immunother; 1987 Aug; 24(1):57-63. PubMed ID: 3102063
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of forphenicinol, a low molecular weight immunomodifier, on the growth of and the immune responses to murine lymphoma EL4.
    Okura A, Naito K, Iizuka H, Ishizuka M, Takeuchi T, Umezawa H.
    J Biol Response Mod; 1987 Feb; 6(1):35-43. PubMed ID: 3559627
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.
    Ishizuka M, Masuda T, Kanbayashi N, Watanabe Y, Matsuzaki M, Sawazaki Y, Ohkura A, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1982 Aug; 35(8):1049-54. PubMed ID: 7142006
    [Abstract] [Full Text] [Related]

  • 9. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K, Tanaka T, Takeuchi M.
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [Abstract] [Full Text] [Related]

  • 10. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T.
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms.
    Naito K, Arakawa H, Watanabe Y, Okura A, Ishizuka M, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1987 Apr; 40(4):547-54. PubMed ID: 3034847
    [Abstract] [Full Text] [Related]

  • 12. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
    Ishizuka M, Masuda T, Mizutani S, Osono M, Kumagai H, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
    [Abstract] [Full Text] [Related]

  • 13. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
    Kataoka T, Oh-hashi F, Sakurai Y, Gomi K.
    Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effects of beryllium and other adjuvants on Ia expression by macrophages.
    Behbehani K, Beller DI, Unanue ER.
    J Immunol; 1985 Apr; 134(4):2047-9. PubMed ID: 3855928
    [No Abstract] [Full Text] [Related]

  • 16. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW, Leu NR, Shannon BJ, Fast DJ.
    J Immunol; 1991 Sep 15; 147(6):1816-22. PubMed ID: 1909732
    [Abstract] [Full Text] [Related]

  • 17. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
    Kataoka T.
    Gan To Kagaku Ryoho; 1986 Mar 15; 13(3 Pt 2):701-5. PubMed ID: 3963841
    [Abstract] [Full Text] [Related]

  • 18. Stimulatory effect of forphenicinol on normal human bone marrow granulocyte-macrophage progenitor cells mediated by T-lymphocytes.
    Ohhara N, Okamura S, Otsuka T, Harada M, Niho Y.
    Biomed Pharmacother; 1987 Mar 15; 41(8):425-8. PubMed ID: 3502533
    [Abstract] [Full Text] [Related]

  • 19. Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine.
    Sharma BS, Balazs L, Jin A, Wang JC, Jolley WB, Robins RK.
    Cancer Immunol Immunother; 1991 Mar 15; 33(2):109-14. PubMed ID: 2036658
    [Abstract] [Full Text] [Related]

  • 20. Prevention and treatment of L1210 mouse leukemia by immunization with xenogenized tumor cells combined with immunostimulation by the P40 fraction of C. granulosum and chemotherapy.
    Relyveld EH, Bizzini B, Ben-Efraim S.
    Int J Immunopharmacol; 1984 Mar 15; 6(5):445-50. PubMed ID: 6500782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.